WCM
HRMY icon

Wedge Capital Management’s Harmony Biosciences HRMY Stock Holding History

Wedge Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Sell
82,530
-6,469
-7% -$204K 0.05% 265
2026
Q1 		$2.49M Buy
88,999
+102
+0.1% +$3.35K 0.05% 294
2025
Q4 		$3.33M Buy
+88,897
New +$2.92M 0.06% 258

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wedge Capital Management's HRMY Position: Q2 2026 in Review

Wedge Capital Management reduced its Harmony Biosciences (HRMY) stake by 7.3% in Q2 2026, selling an estimated $204K and leaving 82,530 shares worth $3M. The position accounts for 0.05% of the portfolio, ranked #265.

Wedge Capital Management first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.33M in Q4 2025. 51 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Wedge Capital Management held 82,530 shares of Harmony Biosciences worth $3M as of Q2 2026.
  • Wedge Capital Management sold 6,469 Harmony Biosciences shares in Q2 2026, an estimated $204K.
  • Harmony Biosciences made up 0.05% of Wedge Capital Management's portfolio in Q2 2026, its #265 holding.
  • Wedge Capital Management first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Wedge Capital Management's Harmony Biosciences position peaked at $3.33M in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.